» Articles » PMID: 12608540

Microsomal Cytochrome P450 Levels and Activities of Isolated Rat Livers Perfused with Albumin

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2003 Mar 1
PMID 12608540
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We recently showed that the perfusion of isolated rat livers with perfusates containing bovine serum albumin (BSA) would significantly stimulate the release of tumor necrosis factor (TNF)-alpha. Here, we hypothesize that BSA-induced increase in the release of TNF-alpha, and possibly other cytokines, would affect cytochrome P450 (CYP)-mediated drug metabolism.

Methods: Rat livers were perfused ex vivo for 1, 2, or 3 h with a physiologic buffer containing or lacking 1% BSA (n = 4-5/group). At the end of perfusion, liver microsomes were prepared and analyzed for their total CYP, CYP2E1, CYP3A2, and CYP2C11 protein contents and the activities of cytochrome c reductase, CYP2E1, CYP3A2, CYP2C11, CYP2E1, CYP2D1, CYP1A1, and CYP2B1/2. In addition, the concentrations of various cytokines and nitric oxide were quantified in the outlet perfusate.

Results: In the absence of BSA, the perfusate levels of all measured cytokines and nitric oxide were low. However, when the perfusate contained BSA, the levels of TNF-alpha, interleukin-6, and nitric oxide increased significantly (p < 0.005). Perfusion of the livers for 3 h with the BSA-containing perfusate resulted in significant (p < 0.05) decreases in the total CYP (41%), CYP2E1 (59%), CYP3A2 (68%), and CYP2C11 (50%) protein contents and activities of cytochrome c reductase (31%), CYP2E1 (66%), CYP3A2 (54%), and CYP2G11 (51%). In contrast, perfusion of livers for 1 or 2 h with the BSA perfusate did not have any significant effect on CYP-mediated metabolism. The CYP1A2, CYP2D1, and CYP2B1/2 activities were not affected by BSA, regardless of perfusion time.

Conclusion: Addition of BSA to perfusates, which is a routine practice in isolated rat liver studies, can reduce CYP-mediated drug metabolism by a mechanism independent of protein-binding effect.

Citing Articles

Current status and challenges of cytokine pharmacology.

Zidek Z, Anzenbacher P, Kmonickova E Br J Pharmacol. 2009; 157(3):342-61.

PMID: 19371342 PMC: 2707982. DOI: 10.1111/j.1476-5381.2009.00206.x.


Protective effects of diallyl sulfide, a garlic constituent, on the warm hepatic ischemia-reperfusion injury in a rat model.

Shaik I, George J, Thekkumkara T, Mehvar R Pharm Res. 2008; 25(10):2231-42.

PMID: 18626753 DOI: 10.1007/s11095-008-9601-8.

References
1.
Warren G, Poloyac S, Gary D, Mattson M, Blouin R . Hepatic cytochrome P-450 expression in tumor necrosis factor-alpha receptor (p55/p75) knockout mice after endotoxin administration. J Pharmacol Exp Ther. 1999; 288(3):945-50. View

2.
Weinhold L, Weinstock C, Hoffmann R, Northoff H, Decker K . Production of tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in the perfused rat liver. Eur Cytokine Netw. 1993; 4(5):363-70. View

3.
Evans A, Hussein Z, Rowland M . Influence of albumin on the distribution and elimination kinetics of diclofenac in the isolated perfused rat liver: analysis by the impulse-response technique and the dispersion model. J Pharm Sci. 1993; 82(4):421-8. DOI: 10.1002/jps.2600820417. View

4.
Roe A, Poloyac S, Howard G, Shedlofsky S, Blouin R . The effect of endotoxin on hepatocyte nuclear factor 1 nuclear protein binding: potential implications on CYP2E1 expression in the rat. J Pharm Pharmacol. 2001; 53(10):1365-71. DOI: 10.1211/0022357011777864. View

5.
Morgan E, Thomas K, Swanson R, Vales T, Hwang J, Wright K . Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver. Biochim Biophys Acta. 1994; 1219(2):475-83. DOI: 10.1016/0167-4781(94)90074-4. View